CSR
Centerspace
REIT - Residential
Market Cap$1.13B
5Y Perf.-4.8%
Compare Stocks
3 / 10Try these comparisons:
Stock Comparison
CSR vs NHI vs IRT
Revenue, margins, valuation, and 5-year total return — side by side.
NHI
National Health Investors, Inc.
REIT - Healthcare Facilities
Market Cap$3.64B
5Y Perf.+35.3%
IRT
Independence Realty Trust, Inc.
REIT - Residential
Market Cap$3.86B
5Y Perf.+65.5%
CSR vs NHI vs IRT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CSR | NHI | IRT |
|---|---|---|---|
| Industry | REIT - Residential | REIT - Healthcare Facilities | REIT - Residential |
| Market Cap | $1.13B | $3.64B | $3.86B |
| Revenue (TTM) | $272M | $403M | $662M |
| Net Income (TTM) | $8M | $148M | $48M |
| Gross Margin | 38.3% | 61.3% | 20.2% |
| Operating Margin | 2.8% | 48.5% | 17.5% |
| Forward P/E | 66.2x | 22.2x | 99.9x |
| Total Debt | $1.02B | $1.16B | $2.28B |
| Cash & Equiv. | $13M | $20M | $48M |
CSR vs NHI vs IRT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CSR
NHI
IRT
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Centerspace (CSR) | 100 | 95.2 | -4.8% |
| National Health Inv… (NHI) | 100 | 135.3 | +35.3% |
| Independence Realty… (IRT) | 100 | 165.5 | +65.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CSR vs NHI vs IRT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: NHI leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Centerspace is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CSR
Centerspace
The Real Estate Income Play
CSR is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.29, yield 4.5%
- Rev growth 35.3%, EPS growth 180.3%, 3Y rev CAGR 11.2%
- Lower volatility, beta 0.29, current ratio 0.27x
Best for: income & stability and growth exposure
NHI
National Health Investors, Inc.
The Real Estate Income Play
NHI carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (22.2x vs 99.9x)
- 36.8% margin vs CSR's 3.1%
- 4.8% yield, 1-year raise streak, vs IRT's 4.0%
Best for: value and quality
IRT
Independence Realty Trust, Inc.
The Real Estate Income Play
IRT is the clearest fit if your priority is long-term compounding.
- 191.8% 10Y total return vs NHI's 58.9%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CSR | 35.3% FFO/revenue growth vs IRT's 2.8% |
| Value | NHI | Lower P/E (22.2x vs 99.9x) |
| Quality / Margins | NHI | 36.8% margin vs CSR's 3.1% |
| Stability / Safety | CSR | Beta 0.29 vs IRT's 0.48 |
| Dividends | NHI | 4.8% yield, 1-year raise streak, vs IRT's 4.0% |
| Momentum (1Y) | CSR | +16.4% vs IRT's -11.9% |
| Efficiency (ROA) | NHI | 5.4% ROA vs CSR's 0.4%, ROIC 5.6% vs 4.2% |
CSR vs NHI vs IRT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
FY 2018
CSR vs NHI vs IRT — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLNHILAGGINGIRT
IRTIndependence Realty T…
0leads
CSRCenterspace
0leads
NHINational Health Inves…
4leads
6 Total Categories
CATEGORYLEADERvs CSRvs IRTMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
NHI6/6
Valuation MetricsMultiples, price ratios, and targets
NHI3/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
NHI6/9
Total Returns1Y, 3Y, 5Y total returns with dividends
NHI3/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
NHI leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IRT is the larger business by revenue, generating $662M annually — 2.4x CSR's $272M. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to CSR's 3.1%. On growth, NHI holds the edge at +29.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CSRCenterspace | NHINational Health I… | IRTIndependence Real… |
|---|---|---|---|
| RevenueTrailing 12 months | $272M | $403M | $662M |
| EBITDAEarnings before interest/tax | $121M | $282M | $365M |
| Net IncomeAfter-tax profit | $8M | $148M | $48M |
| Free Cash FlowCash after capex | $70M | $226M | $139M |
| Gross MarginGross profit ÷ Revenue | +38.3% | +61.3% | +20.2% |
| Operating MarginEBIT ÷ Revenue | +2.8% | +48.5% | +17.5% |
| Net MarginNet income ÷ Revenue | +3.1% | +36.8% | +7.3% |
| FCF MarginFCF ÷ Revenue | +25.8% | +56.1% | +21.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.0% | +29.7% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.5% | +10.8% | -101.4% |
NHI leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
NHI leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 24.9x trailing earnings, NHI trades at a 64% valuation discount to IRT's 68.2x P/E. On an enterprise value basis, CSR's 9.9x EV/EBITDA is more attractive than NHI's 17.2x.
| Metric | CSRCenterspace | NHINational Health I… | IRTIndependence Real… |
|---|---|---|---|
| Market CapShares × price | $1.1B | $3.6B | $3.9B |
| Enterprise ValueMkt cap + debt − cash | $2.1B | $4.8B | $6.1B |
| Trailing P/EPrice ÷ TTM EPS | 66.19x | 24.85x | 68.21x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 22.17x | 99.88x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — |
| EV / EBITDAEnterprise value multiple | 9.91x | 17.16x | 16.71x |
| Price / SalesMarket cap ÷ Revenue | 3.21x | 9.61x | 5.87x |
| Price / BookPrice ÷ Book value/share | 1.34x | 2.29x | 1.07x |
| Price / FCFMarket cap ÷ FCF | 17.64x | 16.52x | 26.33x |
NHI leads this category, winning 3 of 6 comparable metrics.
Profitability & Efficiency
NHI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
NHI delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $1 for CSR. IRT carries lower financial leverage with a 0.64x debt-to-equity ratio, signaling a more conservative balance sheet compared to CSR's 1.21x. On the Piotroski fundamental quality scale (0–9), NHI scores 6/9 vs CSR's 5/9, reflecting solid financial health.
| Metric | CSRCenterspace | NHINational Health I… | IRTIndependence Real… |
|---|---|---|---|
| ROE (TTM)Return on equity | +1.0% | +9.8% | +1.3% |
| ROA (TTM)Return on assets | +0.4% | +5.4% | +0.8% |
| ROICReturn on invested capital | +4.2% | +5.6% | +1.6% |
| ROCEReturn on capital employed | +5.9% | +8.0% | +2.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.21x | 0.76x | 0.64x |
| Net DebtTotal debt minus cash | $1.0B | $1.1B | $2.2B |
| Cash & Equiv.Liquid assets | $13M | $20M | $48M |
| Total DebtShort + long-term debt | $1.0B | $1.2B | $2.3B |
| Interest CoverageEBIT ÷ Interest expense | 1.52x | 3.45x | 1.73x |
NHI leads this category, winning 6 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
NHI leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NHI five years ago would be worth $13,097 today (with dividends reinvested), compared to $11,555 for CSR. Over the past 12 months, CSR leads with a +16.4% total return vs IRT's -11.9%. The 3-year compound annual growth rate (CAGR) favors NHI at 20.2% vs IRT's 2.4% — a key indicator of consistent wealth creation.
| Metric | CSRCenterspace | NHINational Health I… | IRTIndependence Real… |
|---|---|---|---|
| YTD ReturnYear-to-date | +2.0% | -1.1% | -6.0% |
| 1-Year ReturnPast 12 months | +16.4% | +2.8% | -11.9% |
| 3-Year ReturnCumulative with dividends | +28.7% | +73.5% | +7.4% |
| 5-Year ReturnCumulative with dividends | +15.5% | +31.0% | +17.8% |
| 10-Year ReturnCumulative with dividends | +53.6% | +58.9% | +191.8% |
| CAGR (3Y)Annualised 3-year return | +8.8% | +20.2% | +2.4% |
NHI leads this category, winning 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — CSR and NHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than IRT's 0.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSR currently trades 97.0% from its 52-week high vs NHI's 82.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CSRCenterspace | NHINational Health I… | IRTIndependence Real… |
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.29x | -0.08x | 0.48x |
| 52-Week HighHighest price in past year | $69.61 | $90.94 | $19.61 |
| 52-Week LowLowest price in past year | $52.76 | $68.80 | $14.60 |
| % of 52W HighCurrent price vs 52-week peak | +97.0% | +82.5% | +83.5% |
| RSI (14)Momentum oscillator 0–100 | 58.5 | 28.0 | 62.4 |
| Avg Volume (50D)Average daily shares traded | 120K | 332K | 2.2M |
Evenly matched — CSR and NHI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — NHI and IRT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CSR as "Buy", NHI as "Hold", IRT as "Buy". Consensus price targets imply 22.7% upside for IRT (target: $20) vs 1.5% for CSR (target: $69). For income investors, NHI offers the higher dividend yield at 4.80% vs IRT's 4.02%.
| Metric | CSRCenterspace | NHINational Health I… | IRTIndependence Real… |
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $68.50 | $85.40 | $20.08 |
| # AnalystsCovering analysts | 11 | 18 | 27 |
| Dividend YieldAnnual dividend ÷ price | +4.5% | +4.8% | +4.0% |
| Dividend StreakConsecutive years of raises | 2 | 1 | 4 |
| Dividend / ShareAnnual DPS | $3.04 | $3.61 | $0.66 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | 0.0% | +0.8% |
Evenly matched — NHI and IRT each lead in 1 of 2 comparable metrics.
Key Takeaway
NHI leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.
Best OverallNational Health Investors, … (NHI)Leads 4 of 6 categories
Loading custom metrics...
CSR vs NHI vs IRT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CSR or NHI or IRT a better buy right now?
For growth investors, Centerspace (CSR) is the stronger pick with 35.
3% revenue growth year-over-year, versus 2. 8% for Independence Realty Trust, Inc. (IRT). National Health Investors, Inc. (NHI) offers the better valuation at 24. 9x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate Centerspace (CSR) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CSR or NHI or IRT?
On trailing P/E, National Health Investors, Inc.
(NHI) is the cheapest at 24. 9x versus Independence Realty Trust, Inc. at 68. 2x. On forward P/E, National Health Investors, Inc. is actually cheaper at 22. 2x.
03Which is the better long-term investment — CSR or NHI or IRT?
Over the past 5 years, National Health Investors, Inc.
(NHI) delivered a total return of +31. 0%, compared to +15. 5% for Centerspace (CSR). Over 10 years, the gap is even starker: IRT returned +191. 8% versus CSR's +53. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CSR or NHI or IRT?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 08β versus Independence Realty Trust, Inc. 's 0. 48β — meaning IRT is approximately -676% more volatile than NHI relative to the S&P 500. On balance sheet safety, Independence Realty Trust, Inc. (IRT) carries a lower debt/equity ratio of 64% versus 121% for Centerspace — giving it more financial flexibility in a downturn.
05Which is growing faster — CSR or NHI or IRT?
By revenue growth (latest reported year), Centerspace (CSR) is pulling ahead at 35.
3% versus 2. 8% for Independence Realty Trust, Inc. (IRT). On earnings-per-share growth, the picture is similar: Centerspace grew EPS 180. 3% year-over-year, compared to -3. 5% for National Health Investors, Inc.. Over a 3-year CAGR, CSR leads at 11. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CSR or NHI or IRT?
National Health Investors, Inc.
(NHI) is the more profitable company, earning 37. 6% net margin versus 5. 0% for Centerspace — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus 18. 4% for IRT. At the gross margin level — before operating expenses — NHI leads at 36. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CSR or NHI or IRT more undervalued right now?
On forward earnings alone, National Health Investors, Inc.
(NHI) trades at 22. 2x forward P/E versus 99. 9x for Independence Realty Trust, Inc. — 77. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IRT: 22. 7% to $20. 08.
08Which pays a better dividend — CSR or NHI or IRT?
All stocks in this comparison pay dividends.
National Health Investors, Inc. (NHI) offers the highest yield at 4. 8%, versus 4. 0% for Independence Realty Trust, Inc. (IRT).
09Is CSR or NHI or IRT better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 8% yield). Both have compounded well over 10 years (NHI: +58. 9%, IRT: +191. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CSR and NHI and IRT?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CSR is a small-cap high-growth stock; NHI is a small-cap income-oriented stock; IRT is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(CSR: -3.0% · NHI: 29.7%)Net Margin>
%
(CSR: 3.1% · NHI: 36.8%)P/E Ratio<
x
(CSR: 66.2x · NHI: 24.9x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.